JPRN-UMIN000021824已完成未知
The efficacy and safety of Helicobacter pylori eradication therapy using vonoprazan - The efficacy and safety of H. pylori eradication therapy using vonoprazan
Medical corporation Yamashita Hospital0 个研究点目标入组 800 人开始时间: 2016年4月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Past history of allergy for these medications, Vonoprazan, Amoxicillin, Clarithromycin, and Metronidazole used in this therapy.
研究者
相似试验
招募中
2 期
Helicobacter pylori eradication therapy with Vonoprazan, reduced dosage of amoxicillin, and clarithromycin for hemodialysis patientsHelicobacter pylori infectionHelicobacter pyloriJPRN-jRCTs031200237Soichiro Sue23
招募中
2 期
Helicobacter pylori eradication therapy with vonoprazan, clarithromycin, and metronidazole for chronic kidney disease patientsHelicobacter pyloriHelicobacter pylori infectionJPRN-jRCTs031200239Sue Soichiro24
尚未招募
不适用
Safety of Helicobacter pylori eradication therapy in patients with inflammatory bowel diseaseJPRN-UMIN000017105Osaka medical collage100
招募中
不适用
Efficacy of tailored Helicobacter pylori eradication therapy based on susceptibility to antimicrobial agentsH. pylori-associated gastritisJPRN-UMIN000030270Shiga University of Medical Science Hospital310
已完成
不适用
Beneficial effects of helicobacter pylori eradication on severity and frequency of migrane headacheMigrane.Migraine without aura [common migraine]IRCT201202018896N1Vice-chancellor for research of Hamedan University of Medical Sciences80